World first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men

The Medicines and Healthcare products Regulatory Agency (MHRA) has approved trofolastat (RoTecPSMA), the first prostate-specific membrane antigen (PSMA)-targeting product authorised for use with technetium-99m to detect cancerous lesions in men…

Continue ReadingWorld first as MHRA approves trofolastat for diagnostic imaging of prostate cancer in men

Long-term Transcendental Meditation shown to improve stress and aging markers

A collaborative study conducted by researchers at Maharishi International University (MIU), the University of Siegen, and the Uniformed Services University of the Health Sciences reveals that individuals practicing Transcendental Meditation…

Continue ReadingLong-term Transcendental Meditation shown to improve stress and aging markers

Tirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF

The drug tirzepatide improved kidney function and cardiovascular outcomes among patients with obesity and heart failure with preserved ejection fraction (HFpEF) compared with placebo at one year, according to featured…

Continue ReadingTirzepatide improves kidney, cardiovascular function in patients with obesity and HFpEF